共 110 条
[11]
Sharifi M(2016)Transcription factors as readers and effectors of DNA methylation [J] Nat Rev Genet 17 551-565
[12]
Jiang X(2019)Hypermethylation of mismatch repair gene hMSH2 associates with platinum-resistant disease in epithelial ovarian cancer [J] Clin Epigenetics 11 153-330
[13]
Li X(2017)DNA methylation and Transcriptome Changes Associated with Cisplatin Resistance in Ovarian Cancer [J] Sci Rep 7 1469-169
[14]
Li W(2019)Methylation and ovarian cancer: Can DNA methylation be of diagnostic use?[J] Mol Clin Oncol 10 323-3785
[15]
van Zyl B(2019)Hypermethylation of tumor suppressor genes is a risk factor for poor prognosis in ovarian cancer: A meta-analysis [J] Medicine (Baltimore) 98 160-2293
[16]
Tang D(2018)Epigenetics in ovarian cancer [J] Semin Cancer Biol 51 3775-644
[17]
Bowden NA(2020)Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes [J] Cancer Res 80 7-599
[18]
Christie EL(2019)Epigenetic therapy for ovarian cancer: promise and progress [J] Clin Epigenetics 11 2285-182
[19]
Bowtell DDL(2018)A Phase I Clinical Trial of Guadecitabine and Carboplatin in Platinum-Resistant, Recurrent Ovarian Cancer: Clinical, Pharmacokinetic, and Pharmacodynamic Analyses [J] Clin Cancer Res 24 631-2818
[20]
Freimund AE(2017)The safety, efficacy, and treatment outcomes of a combination of low-dose decitabine treatment in patients with recurrent ovarian cancer [J] Oncoimmunology 6 214-296